Annual CFF
-$337.50 M
-$170.10 M-101.62%
December 31, 2024
Summary
- As of March 6, 2025, GDRX annual cash flow from financing activities is -$337.50 million, with the most recent change of -$170.10 million (-101.62%) on December 31, 2024.
- During the last 3 years, GDRX annual CFF has fallen by -$306.97 million (-1005.53%).
- GDRX annual CFF is now -137.26% below its all-time high of $905.82 million, reached on December 31, 2020.
Performance
GDRX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$3.53 M
+$168.60 M+97.95%
December 31, 2024
Summary
- As of March 6, 2025, GDRX quarterly cash flow from financing activities is -$3.53 million, with the most recent change of +$168.60 million (+97.95%) on December 31, 2024.
- Over the past year, GDRX quarterly CFF has increased by +$168.60 million (+97.95%).
- GDRX quarterly CFF is now -100.36% below its all-time high of $992.12 million, reached on September 30, 2020.
Performance
GDRX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$337.50 M
+$122.08 M+26.56%
December 31, 2024
Summary
- As of March 6, 2025, GDRX TTM cash flow from financing activities is -$337.50 million, with the most recent change of +$122.08 million (+26.56%) on December 31, 2024.
- Over the past year, GDRX TTM CFF has increased by +$122.08 million (+26.56%).
- GDRX TTM CFF is now -133.18% below its all-time high of $1.02 billion, reached on September 30, 2020.
Performance
GDRX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GDRX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -101.6% | +98.0% | +26.6% |
| 3 y3 years | -1005.5% | +74.2% | -624.6% |
| 5 y5 years | -516.1% | +74.2% | -624.6% |
GDRX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1005.5% | at low | -308.6% | +98.0% | -1005.5% | +26.6% |
| 5 y | 5-year | -137.3% | at low | -100.4% | +98.0% | -133.2% | +26.6% |
| alltime | all time | -137.3% | at low | -100.4% | +98.0% | -133.2% | +26.6% |
GoodRx Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$337.50 M(+101.6%) | -$3.53 M(-97.9%) | -$337.50 M(-26.6%) |
| Sep 2024 | - | -$172.13 M(>+9900.0%) | -$459.57 M(+52.6%) |
| Jun 2024 | - | -$864.00 K(-99.5%) | -$301.15 M(-4.2%) |
| Mar 2024 | - | -$160.97 M(+28.2%) | -$314.28 M(+87.7%) |
| Dec 2023 | -$167.40 M(+39.2%) | -$125.61 M(+816.4%) | -$167.40 M(+259.4%) |
| Sep 2023 | - | -$13.71 M(-2.1%) | -$46.58 M(-14.7%) |
| Jun 2023 | - | -$13.99 M(-0.7%) | -$54.58 M(+27.2%) |
| Mar 2023 | - | -$14.09 M(+194.4%) | -$42.91 M(-64.3%) |
| Dec 2022 | -$120.23 M | -$4.79 M(-78.0%) | -$120.23 M(-5.3%) |
| Sep 2022 | - | -$21.71 M(+832.6%) | -$126.91 M(+16.0%) |
| Jun 2022 | - | -$2.33 M(-97.5%) | -$109.37 M(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$91.40 M(+697.2%) | -$107.91 M(+253.5%) |
| Dec 2021 | -$30.53 M(-103.4%) | -$11.46 M(+174.3%) | -$30.53 M(-76.6%) |
| Sep 2021 | - | -$4.18 M(+383.2%) | -$130.44 M(-115.1%) |
| Jun 2021 | - | -$865.00 K(-93.8%) | $865.87 M(+0.2%) |
| Mar 2021 | - | -$14.02 M(-87.4%) | $864.20 M(-4.6%) |
| Dec 2020 | $905.82 M(-1753.5%) | -$111.37 M(-111.2%) | $905.82 M(-10.9%) |
| Sep 2020 | - | $992.12 M(<-9900.0%) | $1.02 B(+3957.6%) |
| Jun 2020 | - | -$2.53 M(-109.2%) | $25.07 M(-9.2%) |
| Mar 2020 | - | $27.60 M | $27.60 M |
| Dec 2019 | -$54.78 M(+121.5%) | - | - |
| Dec 2018 | -$24.73 M | - | - |
FAQ
- What is GoodRx Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for GoodRx Holdings?
- What is GoodRx Holdings annual CFF year-on-year change?
- What is GoodRx Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for GoodRx Holdings?
- What is GoodRx Holdings quarterly CFF year-on-year change?
- What is GoodRx Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for GoodRx Holdings?
- What is GoodRx Holdings TTM CFF year-on-year change?
What is GoodRx Holdings annual cash flow from financing activities?
The current annual CFF of GDRX is -$337.50 M
What is the all time high annual CFF for GoodRx Holdings?
GoodRx Holdings all-time high annual cash flow from financing activities is $905.82 M
What is GoodRx Holdings annual CFF year-on-year change?
Over the past year, GDRX annual cash flow from financing activities has changed by -$170.10 M (-101.62%)
What is GoodRx Holdings quarterly cash flow from financing activities?
The current quarterly CFF of GDRX is -$3.53 M
What is the all time high quarterly CFF for GoodRx Holdings?
GoodRx Holdings all-time high quarterly cash flow from financing activities is $992.12 M
What is GoodRx Holdings quarterly CFF year-on-year change?
Over the past year, GDRX quarterly cash flow from financing activities has changed by +$168.60 M (+97.95%)
What is GoodRx Holdings TTM cash flow from financing activities?
The current TTM CFF of GDRX is -$337.50 M
What is the all time high TTM CFF for GoodRx Holdings?
GoodRx Holdings all-time high TTM cash flow from financing activities is $1.02 B
What is GoodRx Holdings TTM CFF year-on-year change?
Over the past year, GDRX TTM cash flow from financing activities has changed by +$122.08 M (+26.56%)